Frances M. Gotch

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

The prevalence of human leucocyte antigen and human papillomavirus DNA in penile intraepithelial neoplasia in England 2011-2012.

The prevalence of human leucocyte antigen and human papillomavirus DNA in penile intraepithelial neoplasia in England 2011-2012.

Journal: International journal of STD & AIDS

Published: February 12, 2021

Immunogenetics and human papillomavirus (HPV) in male genital lichen sclerosus (MGLSc).

Immunogenetics and human papillomavirus (HPV) in male genital lichen sclerosus (MGLSc).

Journal: International journal of STD & AIDS

Published: October 21, 2020

HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment.

HLA Immunogenotype Determines Persistent Human Papillomavirus Virus Infection in HIV-Infected Patients Receiving Antiretroviral Treatment.

Journal: The Journal of infectious diseases

Published: September 27, 2015

Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection.

Loss of Th22 cells is associated with increased immune activation and IDO-1 activity in HIV-1 infection.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: October 15, 2014

Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.

Frequencies of Gag-restricted T-cell escape "footprints" differ across HIV-1 clades A1 and D chronically infected Ugandans irrespective of host HLA B alleles.

Journal: Vaccine

Published: September 17, 2014

Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.

Priming with a simplified intradermal HIV-1 DNA vaccine regimen followed by boosting with recombinant HIV-1 MVA vaccine is safe and immunogenic: a phase IIa randomized clinical trial.

Journal: PloS one

Published: September 02, 2014

CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8+ T-cell immune activation.

CD8+/CD161++ mucosal-associated invariant T-cell levels in the colon are restored on long-term antiretroviral therapy and correlate with CD8+ T-cell immune activation.

Journal: AIDS (London, England)

Published: June 10, 2014

Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection.

Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection.

Journal: Vaccine

Published: September 26, 2013

Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy.

Dysregulated immunophenotypic attributes of plasmacytoid but not myeloid dendritic cells in HIV-1 infected individuals in the absence of highly active anti-retroviral therapy.

Journal: Clinical and experimental immunology

Published: October 09, 2012

Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011.

Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011.

Journal: Journal of translational medicine

Published: May 14, 2012

Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection.

Single-nucleotide polymorphism-defined class I and class III major histocompatibility complex genetic subregions contribute to natural long-term nonprogression in HIV infection.

Journal: The Journal of infectious diseases

Published: January 13, 2012

Showing 1-11 of 11

Last Updated: 09/26/2026